key: cord-0761848-725420ok
authors: Sahara, Toshinori; Yokota, Kazuhisa
title: Concurrent COVID-19 and Tuberculosis in an Immigrant Worker Presenting with Hemoptysis
date: 2021-07-16
journal: Am J Trop Med Hyg
DOI: 10.4269/ajtmh.21-0477
sha: 6f2fe77d44e3e5fd1b9496199347505427b56f6e
doc_id: 761848
cord_uid: 725420ok

nan

pyrazinamide) from day 9 after admission. His fever decreased the following day, his productive cough improved gradually, and his appetite returned. The sputum culture subsequently tested positive for Mycobacterium tuberculosis, which was sensitive to every anti-TB drug.

The prevalence of hemoptysis in patients with COVID-19 and TB has been reported as 2% 1 and as approximately 8%. 2,3 Elise et al. 4 reported a COVID-19 case with acuteonset hemoptysis, and another report indicated that the duration of hemoptysis in patients with COVID-19 may be less than 10 days. 5 This case exemplifies the importance of being aware of possible concurrent infections in patients with COVID-19, and that correct assessment of patients at appropriate times is essential to identify co-infections. The epidemiological background of TB, clinical pattern of symptom onset, and period of hemoptysis are key to recognizing concurrent infection of TB among patients with COVID-19 presenting hemoptysis.

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis

Death-producing hemoptysis in tuberculosis

Pulmonary tuberculosis: the essentials

Hemoptysis as the first presentation of COVID-19: a case report

novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features

Acknowledgment: We thank all of the staff in the COVID-19 ward at Ebara Hospital for their assistance with clinical management.Authors' addresses: Toshinori Sahara and Kazuhisa Yokota, Department of Infectious Diseases, Ebara Hospital, Tokyo Metropolitan Health and Hospital Corporation, Tokyo, Japan, E-mails: saharakote-tu@gmail.com and yokota77@gmail.com.

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.